Bortezomib is often a proteasome inhibitor employed to take care of various myeloma in people which have not been effectively taken care of with no less than two prior therapies. levoketoconazole will increase the degree or result of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Aged: https://stephenb444tfp7.yomoblog.com/profile